Phase 2 IPF Study Now Enrolling Learn More »
Phase 2 SSc Study Now Enrolling Learn More »
Mediar Therapeutics

Our Mission

Fearlessly pioneering novel therapies to make meaningful impact and provide hope for patients with fibrotic diseases.

Simon Sturge LinkedIn for Simon Sturge

Chairman

Cassidy Blundell, PhD LinkedIn for Cassidy Blundell, PhD

Mission BioCapital

Allan Marchington, PhD LinkedIn for Allan Marchington, PhD

ICG

Rahul Ballal, PhD LinkedIn for Rahul Ballal, PhD

Mediar Therapeutics

Adam Cotton LinkedIn for Adam Cotton

Novartis Venture Fund

Marie-Claire Peakman, PhD LinkedIn for Marie-Claire Peakman, PhD

Pfizer Ventures

Maina Bhaman LinkedIn for Maina Bhaman

Sofinnova Partners

Andreas Jurgeit, PhD LinkedIn for Andreas Jurgeit, PhD

Gimv

Bharat Srinivasa, PhD LinkedIn for Bharat Srinivasa, PhD

Amplitude